India Begins Phase 3 Clinical Trial With 1st Indigenous Dengue Vaccine
New Delhi: In a significant development, the Indian Council of Medical Research (ICMR) and Panacea Biotec on Wednesday announced they have ...
New Delhi: In a significant development, the Indian Council of Medical Research (ICMR) and Panacea Biotec on Wednesday announced they have ...
New Delhi: Japanese pharma company Takeda on Friday announced that its dengue vaccine candidate, TAK-003, prevented 84 per cent of ...